Were there previous signs that Arava® was associated to serious and potentially fatal adverse effects?
In February 2001, the European Agency for the Evaluation of Medical Products issued a warning to doctors and patients citing nine deaths due to liver failure in Arava® patients. Two months after that, Arava® manufacturer Aventis Pharmaceuticals issued a warning letter to physicians. Last August, the American College of Rheumatology published a warning to doctors and patients urging monthly blood tests be taken in an Arava® patient”s first six months and follow-up tests every two to three months following. If you have suffered from the use of prescription drug Arava®, contact us to learn your rights.
Related Questions
- Most pharmaceutical drugs produce potentially dangerous side effects. What adverse side effects are associated with Bios Life products?
- Most pharmaceutical drugs produce potentially dangerous side effects. What adverse side effects are associated with Bios Life® products?
- Were there previous signs that Arava was associated to serious and potentially fatal adverse effects?
